BPIA joins research effort focused on learning more at field-level about biological products.

Congressman Jimmy Panetta discussed the Plant Biostimulant Act during a House Ag Committee hearing on soil health practices.

BPIA and FACA commend the U.S. Department of Agriculture for its consideration and selection of pilot projects through its Partnerships for Climate-Smart Commodities.

BPIA provided comments regarding the USDA’s Animal and Plant Health Inspection Service’s Strategic Plan Framework,

Making Sense of Biologicals, a series from AgNet West that dives into various topics with unbiased experts in the field of biologics, talked with BPIA.

BPIA hosted its biggest annual meeting ever in Monterey, California.

BPIA applauds the bipartisan introduction of the Plant Biostimulant Act of 2022 and thanks Congressman Jimmy Panetta (D-CA) and Congressman Jim Baird (R-IN) for sponsoring the bill.

The United States Biostimulant Industry Completes Recommended Guidelines to Support Efficacy, Composition, and Safety of Plant Biostimulant Products

California Department of Pesticide Regulation sent a response to BPIA regarding its comments on new policies proposed by the Pesticide Registration Branch.

BPIA submitted comments in response to USDA’s request for public comments on the Climate-Smart Agriculture and Forestry Partnership Program.

BPIA provided feedback to the NOSB in support for continued reference to EPA List 3 Inert Ingredients for use in organic inputs.

BPIA provided feedback following plant biostimulant roundtable hosted by USDA.

The BPIA 2022 Annual Meeting is scheduled for May 17-18, 2022, at the Hyatt Regency Monterey, California.

BPIA recently moderated the Farm Foundation’s Biologicals in Agriculture Forum which surveyed the landscape of biological crop protection in agriculture.

BPIA along with several other trade association sent a letter congratulating Secretary Vilsack and Administrator Regan on their recent confirmations.